Titles: H.R.5651 — 112th Congress (2011-2012)All Information (Except Text)

Short Titles

Short Titles - House of Representatives

Short Titles as Passed House

Food and Drug Administration Reform Act of 2012

Short Titles as Passed House for portions of this bill
  • Biosimilar User Fee Act of 2012
  • Generic Drug User Fee Amendments of 2012
  • Medical Device User Fee Amendments of 2012
  • Prescription Drug User Fee Amendments of 2012

Short Titles as Introduced

Food and Drug Administration Reform Act of 2012

Short Titles as Introduced for portions of this bill
  • Biosimilar User Fee Act of 2012
  • Generic Drug User Fee Amendments of 2012
  • Medical Device User Fee Amendments of 2012
  • Prescription Drug User Fee Amendments of 2012

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.